Assessment of Annabella Breast Pump Performance

Sponsor
Annabella Tech Ltd (Industry)
Overall Status
Recruiting
CT.gov ID
NCT04363073
Collaborator
(none)
50
1
2
27
1.9

Study Details

Study Description

Brief Summary

This is an interventional, prospective, randomized, comparative, two-period cross over study to evaluate the performance of Annabella breast pump against a control breast pump.

Condition or Disease Intervention/Treatment Phase
  • Device: Annabella Breast Pump
  • Device: Control Breast Pump
N/A

Detailed Description

50 women who are 2-5 months post-delivery will be included in the study following appropriate consent. Women will be randomly allocated to two groups for the type of pump used on the first session. Each expression visit will start approximately 3 hours after the end of a regular baby feeding session. Each expression visit will start approximately 3 hours after the end of a regular baby feeding session. During each visit, milk will be expressed once a day from each of the two breasts (left & right). During the 4 first visits (at least 1 day apart) Annabella or the control pump will be used. After at least 3 days washout period, milk will be expressed for additional 4 days, once a day from each of the two breasts, using the other breast pump. An expression session will last until no milk is expressed for 3 min continuously but not for longer than 25 min. Participants will be serving as their own control. Milk will be collected for volume and quality assessment. Maternal comfort at the end of each visit will be assessed using questionnaire.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
50 participants
Allocation:
Randomized
Intervention Model:
Crossover Assignment
Masking:
None (Open Label)
Primary Purpose:
Other
Official Title:
Assessment of Annabella Breast Pump Performance
Actual Study Start Date :
Dec 30, 2020
Anticipated Primary Completion Date :
Dec 1, 2022
Anticipated Study Completion Date :
Apr 1, 2023

Arms and Interventions

Arm Intervention/Treatment
Experimental: Anaabella

Milk will be expressed using Annabella breast pump.

Device: Annabella Breast Pump
Milk will be expressed using Annabella breast pump for 4 consecutive days (at least 24h apart)

Active Comparator: Control pump

Milk will be expressed using a control breast pump.

Device: Control Breast Pump
Milk will be expressed using Control breast pump for 4 consecutive days (at least 24h apart)

Outcome Measures

Primary Outcome Measures

  1. Milk Volume collected using the breast pump [immediately after the intervention]

    Total milk Volume (cc)

Secondary Outcome Measures

  1. Fat Content [immediately after the intervention]

    Fat %

  2. s Satisfaction questionnaires [immediately after the intervention]

    rating scale: Min: 1 , Max: 10; higher score- better outcome

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
Female
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Women ≥ 18 years old

  • Women whom are 2-5 months post delivery

  • Lactating women - Breastfeed with no more than formula feeding twice a day and no solid food feeding (which replace breastfeeding) during the study period.

  • Breastfeed or pumping at least 5 times a day

  • Mother to healthy infant born at ≥ 37 weeks of gestation age.

Exclusion Criteria:
  • Woman who consumes under 1,500 kcal/day (on a diet)

  • Report a high mental stress condition and/or depression

  • Use of estrogen oral contraceptives

  • Pregnant women

  • Suffer from chronic diseases that can impact breast feeding

  • Participate in another clinical trial

  • Mothers of babies who may develop feeding difficulties according to the investigator decisions (such as cleft pallet, autism).

  • Woman with Sunken/ flat nipple or inverted nipple. or any other physiological condition that may disturb breast feeding.

  • Woman that declares at time of recruitment that she is unable to extract more than 25ml per breastfeeding (overall from both breast)

Contacts and Locations

Locations

Site City State Country Postal Code
1 Shamir medical center Be'er Ya'aqov Israel

Sponsors and Collaborators

  • Annabella Tech Ltd

Investigators

  • Principal Investigator: Revital Sheinberg, MD, Shiba Medical Center, Israel

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Annabella Tech Ltd
ClinicalTrials.gov Identifier:
NCT04363073
Other Study ID Numbers:
  • Annabella V1
First Posted:
Apr 27, 2020
Last Update Posted:
Jul 29, 2022
Last Verified:
Feb 1, 2022
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Annabella Tech Ltd

Study Results

No Results Posted as of Jul 29, 2022